Target Name: CITED1
NCBI ID: G4435
Other Name(s): Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1, transcript variant 1 | CITE1_HUMAN | OTTHUMP00000023535 | melanocyte-specific protein 1 | OTTHUMP00000023532 | Cbp/p300-interacting transactivator 1 (isoform 1) | Cbp/p300-interacting transactivator 1 | OTTHUMP00000023531 | OTTHUMP00000023534 | Melanocyte-specific protein 1 | CITED1 variant 1 | OTTHUMP00000023533 | MSG1 | Melanocyte-specific gene 1 | melanocyte-specific gene 1 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1

CATED1: A Potential Drug Target Or Biomarker

CITED1, also known as Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1, is a protein that plays a crucial role in cell signaling pathways. It is a key transcription factor that can interact with the protein p300, which is a well-known transcription factor that plays a role in the regulation of gene expression.

Cuated by its name, CITED1 is localized to the cytoplasm and has been observed to interact with p300. This interaction between the two proteins has led to the idea that CATED1 may be a drug target or biomarker.

One of the main functions of CITED1 is to regulate gene expression. It has been shown to play a role in the regulation of various genes, including those involved in cell adhesion, migration, and invasion. Cately described by Dr. X and colleagues, CATED1 has been shown to be involved in the regulation of the gene involved in the development and maintenance of cancer.

Another function of CATED1 is to play a role in the regulation of cell signaling pathways. It has been shown to interact with several proteins involved in cell signaling, including the protein p300. This interaction between the two proteins has led to the idea that CATED1 may be a drug target or biomarker associated with the regulation of cell signaling pathways.

Cately, Dr. X and colleagues have also shown that CATED1 can interact with the protein p53, which is a well-known tumor suppressor protein. This interaction between the two proteins has led to the idea that CATED1 may be a drug target or biomarker associated with the regulation of tumor suppressor pathways.

In conclusion, CATED1 is a protein that has been shown to interact with several proteins involved in cell signaling pathways. Its role in the regulation of gene expression and cell signaling has led to the idea that it may be a drug target or biomarker. Further research is needed to determine the exact function of CATED1 and its potential as a drug target or biomarker.

Protein Name: Cbp/p300 Interacting Transactivator With Glu/Asp Rich Carboxy-terminal Domain 1

Functions: Transcriptional coactivator of the p300/CBP-mediated transcription complex. Enhances SMAD-mediated transcription by strengthening the functional link between the DNA-binding SMAD transcription factors and the p300/CBP transcription coactivator complex. Stimulates estrogen-dependent transactivation activity mediated by estrogen receptors signaling; stabilizes the interaction of estrogen receptor ESR1 and histone acetyltransferase EP300. Positively regulates TGF-beta signaling through its association with the SMAD/p300/CBP-mediated transcriptional coactivator complex. Induces transcription from estrogen-responsive promoters and protection against cell death. Potentiates EGR2-mediated transcriptional activation activity from the ERBB2 promoter. Acts as an inhibitor of osteoblastic mineralization through a cAMP-dependent parathyroid hormone receptor signaling. May play a role in pigmentation of melanocytes. Associates with chromatin to the estrogen-responsive TGF-alpha promoter region in a estrogen-dependent manner

More Common Targets

CITED2 | CITED4 | CIZ1 | CKAP2 | CKAP2L | CKAP4 | CKAP5 | CKB | CKLF | CKM | CKMT1A | CKMT1B | CKMT2 | CKMT2-AS1 | CKS1B | CKS1BP2 | CKS1BP5 | CKS1BP6 | CKS1BP7 | CKS2 | CLASP1 | CLASP2 | CLASRP | Class III phosphatidylinositol 3-kinase (PI3-kinase) sub-complex | Clathrin | CLBA1 | CLC | CLCA1 | CLCA2 | CLCA3P | CLCA4 | CLCC1 | CLCF1 | CLCN1 | CLCN2 | CLCN3 | CLCN4 | CLCN5 | CLCN6 | CLCN7 | CLCNKA | CLCNKB | CLDN1 | CLDN10 | CLDN10-AS1 | CLDN11 | CLDN12 | CLDN14 | CLDN14-AS1 | CLDN15 | CLDN16 | CLDN17 | CLDN18 | CLDN19 | CLDN2 | CLDN20 | CLDN22 | CLDN23 | CLDN24 | CLDN25 | CLDN3 | CLDN34 | CLDN4 | CLDN5 | CLDN6 | CLDN7 | CLDN8 | CLDN9 | CLDND1 | CLDND2 | Cleavage and polyadenylation specificity factor complex | Cleavage factor Im complex | Cleavage Stimulation Factor | CLEC10A | CLEC11A | CLEC12A | CLEC12A-AS1 | CLEC12B | CLEC14A | CLEC16A | CLEC17A | CLEC18A | CLEC18B | CLEC18C | CLEC19A | CLEC1A | CLEC1B | CLEC2A | CLEC2B | CLEC2D | CLEC2L | CLEC3A | CLEC3B | CLEC4A | CLEC4C | CLEC4D | CLEC4E | CLEC4F | CLEC4G | CLEC4GP1